Sessionsort descending Date
The Progression from Clonal Hematopoiesis to Myeloid Malignancy: A Bench to Bedside Perspective 10/21/2019 - 12:00pm to 1:00pm
Tumor-resident DC impact anti-tumor T cell responses 06/08/2020 - 12:00pm to 1:00pm
Tumor-Specific Mitochondrial DNA Variants as Biomarkers in Head and Neck Malignancies 09/09/2019 - 12:00pm to 1:00pm
Updates in Osteoporosis and Use of Osteoclast Inhibitors 11/11/2019 - 12:00pm to 1:00pm
Using Clinical and Genomic Risk to Personalize Adjuvant Therapy in Breast Cancer and Communicating Prognosis to Patients with Advanced Cancer 08/19/2019 - 12:00pm to 1:00pm
Using Machine Learning to Guide Adjuvant Treatment of Head and Neck Cancer - AND - Improving Safety with Adoptive Cell Therapies 05/04/2020 - 12:00pm to 1:00pm
Weathering the Storm: The COVID-19 Pandemic in Oncology 04/06/2020 - 12:00pm to 1:00pm
Why Metabolic Alterations are Key to Hepatocellular Carcinoma 09/23/2019 - 12:00pm to 1:00pm
“A Spotlight on Cholangiocarcinoma: Emerging Therapies” and “Use of Immunotherapy in HCC” 07/01/2019 - 12:00pm to 1:00pm
“Non-Cytotoxic Epigenetic Drugs to Terminate Cancer but Not Normal Self-Replication” 07/22/2019 - 12:00pm to 1:00pm

Pages